2
Risk stratification in ET
Essential Thrombocythemia AK
Preface
1
Introduction
2
Risk stratification in ET
3
Clinical Guidelines for Peg-IFN-α Usage in Practice
4
INCA33989 Phase 1 Clinical Trial Results in Essential Thrombocythemia - ASH 2025 Update
5
INCA035784 A Novel T Cell-Redirecting Antibody for mutCALR MPN
6
Novel Therapies in ET
7
Summary
References
Table of contents
3
IPSET-Thrombosis
4
Triple-A score for ET
5
AAA+A score
6
MIPSS-ET
7
MPN Personlized Risk Calculator
2
Risk stratification in ET
3
IPSET-Thrombosis
4
Triple-A score for ET
Age
ANC
ALC
5
AAA+A score
Age
ANC
ALC
AMC
6
MIPSS-ET
7
MPN Personlized Risk Calculator
1
Introduction
3
Clinical Guidelines for Peg-IFN-α Usage in Practice